Concepedia

Author

Louise Ferrall

Johns Hopkins UniversityORCID

Also Known As

Ferrall, Louise, L. Ferrall, Louise Ferrall

61

Publications

1.3K

Citations

10

H-Index

7

Concepts

All Affiliations

Johns Hopkins UniversityJohns Hopkins Medicine
LF

About

Louise Ferrall is an author at Johns Hopkins University specializing in tumor microenvironment, radiation oncology, and tumor immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

34

2

Immunology

1

1

34

3

Immunotherapy

1

1

34

4

Tumor Immunology

1

1

34

5

Radiation Oncology

1

1

34

Louise Ferrall

×

7

Publications

235

Citations

7

H-Index

YearCitations

Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody

Shiwen Peng, Louise Ferrall, Stéphanie Gaillard,

mBio

2021

88

A novel pseudovirus‐based mouse model of SARS-CoV-2 infection to test COVID-19 interventions

Ssu-Hsueh Tseng, Brandon Lam, Yu Jui Kung,

Journal of Biomedical Science

2021

46

PD-1 blockade synergizes with intratumoral vaccination of a therapeutic HPV protein vaccine and elicits regression of tumor in a preclinical model

Shiwen Peng, Marietta Tan, Yen-Der Li,

Cancer Immunology Immunotherapy

2020

34

Development of a Novel Mouse Model of Spontaneous High-Risk HPVE6/E7–Expressing Carcinoma in the Cervicovaginal Tract

Talia R. Henkle, Brandon Lam, Yu Jui Kung,

Cancer Research

2021

20

Albumin and interferon-β fusion protein serves as an effective vaccine adjuvant to enhance antigen-specific CD8+ T cell-mediated antitumor immunity

Ssu-Hsueh Tseng, Max A. Cheng, Emily Farmer,

Journal for ImmunoTherapy of Cancer

2022

20

Control of Spontaneous HPV16 E6/E7 Expressing Oral Cancer in HLA-A2 (AAD) Transgenic Mice with Therapeutic HPV DNA Vaccine

Ssu-Hsueh Tseng, Li Liu, Shiwen Peng,

Journal of Biomedical Science

2021

15

Safety Run-in of Intramuscular pNGVL4a-Sig/E7(detox)/HSP70 DNA and TA-CIN Protein Vaccination as Treatment for HPV16+ ASC-US, ASC-H, or LSIL/CIN1

Mark H. Einstein, Richard B.S. Roden, Louise Ferrall,

Cancer Prevention Research

2023

12

Page 1